Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 9,710.00
-410.00 (-4.05%)
At close: Dec 5, 2025
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 53.7 billion as of December 5, 2025. Its market cap has decreased by -31.86% in one year.
Market Cap
53.70B
Enterprise Value
29.95B
Revenue
24.56B
Ranking
n/a
PE Ratio
15.65
Stock Price
9,710.00
Market Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 53.70B, a decrease of -81.33%. That is a compound annual growth rate of -72.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 53.70B | -26.66% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |